A Toronto lawyer is advocating for greater access to a drug used to treat cystic fibrosis.
Chris MacLeod, founding partner at Cambridge LLP, calls Kalydeco “a game changer” and he should know — he has CF and has been on the drug since it became available in 2012. Before starting the medication, he was in the hospital for four months. He hasn’t been back since he started taking the drug.
One pill in the morning and one at night, and the drug essentially halts the progression of CF, he explains.